Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
HR3955119th CongressWALLET
RAPID Reserve Act
Sponsored By: Representative Craig, Angie [D-MN-2]
Introduced
Summary
This bill would create a program to build and maintain a national rolling reserve of critical drugs and active pharmaceutical ingredients (APIs). It sets rules for which medicines qualify, requires contract-backed six-month (or Secretary-determined) reserves of APIs and finished drugs, and pushes for domestic manufacturing and surge capacity.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
National drug reserve to prevent shortages
HHS would create a program to keep a rolling six-month reserve of certain drugs and their ingredients. HHS would publish the covered list, pick eligible companies, and favor domestic manufacturing. Reserves would be stored in approved U.S. sites or certain OECD countries. Awards could pay for storage, testing, delivery, and help build or upgrade non-federal factories. Companies would replenish stock, boost output when asked, and let HHS direct transfers or allocation during emergencies. HHS would issue guidance within 180 days and report to Congress two years after the first award, then every two years. The bill would authorize $500 million for fiscal year 2026.
Sponsors & CoSponsors
Sponsor
Craig, Angie [D-MN-2]
MN • D
Cosponsors
Rep. Van Drew, Jefferson [R-NJ-2]
NJ • R
Sponsored 6/12/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov